« Previous
Next »
Best Practice & Research Clinical Haematology
Volume 21, Issue 1
, Pages 93-98
, March 2008
Are there effective new strategies for the treatment of acute and chronic GvHD?
References
- . Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. Journal of Immunology. 1997;158:3037–3045
- Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. Journal of Immunology. 2000;164:2180–2187
- . Novel excision products of T cell receptor gamma gene rearrangements and developmental stage specificity implied by the frequency of nucleotide insertions at signal joints. European Journal of Immunology. 1992;22:101–106
- T-Cell recovery in adults and children following umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation. 2001;7:454–466
- Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690–695
- Transfer of allogeneic CD62L-memory T cells without graft-versus-host disease. Blood. 2004;103:1534–1541
- Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004;103:4344–4352
- Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biology of Blood and Marrow Transplantation. 2006;12:252–266
- Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. The Journal of Experimental Medicine. 2004;199:1133–1142
- Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood. 2004;103:353–359
- Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 2006;108:756–762
- Inflammatory markers and autoantibodies that correlate with early and late onset of new onset pediatric chronic graft-versus-host disease (GVHD). Blood. 2006;108:923a;[abstract #3232]
- Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 1998;395:284–288
- The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. The Journal of Biological Chemistry. 2000;275:24255–24263
- Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. The Journal of Biological Chemistry. 1999;274:10689–10692
- MEK is a key modulator for TLR5-induced interleukin-8 and MIP3alpha gene expression in non-transformed human colonic epithelial cells. The Journal of Biological Chemistry. 2004;279:25179–25188
- A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740–745
- Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood. 2004;104:889–894
PII: S1521-6926(07)00103-X
doi: 10.1016/j.beha.2007.11.012
© 2007 Elsevier Ltd. All rights reserved.
« Previous
Next »
Best Practice & Research Clinical Haematology
Volume 21, Issue 1
, Pages 93-98
, March 2008
